Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Reexamination Certificate
2006-05-17
2010-10-12
Nguyen, Quang (Department: 1633)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
C435S004000
Reexamination Certificate
active
07811817
ABSTRACT:
Purified preparations of human embryonic stem cells with certain population-specific characteristics are disclosed. This preparation is characterized by the positive expression of the following pluripotent cell surface markers: SSEA-1 (−); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatase (+), as well as a set of ES cell markers including Oct-4, Nanog, Rex1, Sox2, Thy1, FGF4, ABCG2, Dppa5, UTF1, Cripto1, hTERT, Connexin-43 and Connexin-45. The cells of the preparation are negative for lineage specific markers like Keratin 8, Sox-1, NFH (ectoderm), MyoD, brachyury, cardiac-actin (mesoderm), HNF-3 beta, albumin, and PDX1 (endoderm). The cells of the preparation are human embryonic stem cells, have normal karyotypes, exhibit high telomerase activity and continue to proliferate in an undifferentiated state after continuous culture for over 40 passages. The embryonic stem cell line Relicell™ hES1 also retains the ability, throughout the culture, to differentiate into cell and tissue types derived from all three embryonic germ layers (endoderm, mesoderm and ectoderm). Methods for isolating a human embryonic stem cell line are also disclosed.
REFERENCES:
patent: 5843780 (1998-12-01), Thomson
patent: 6200806 (2001-03-01), Thomson
patent: 2003/0073234 (2003-04-01), Amit et al.
patent: 2003/0104616 (2003-06-01), Parikh et al.
patent: 2005/0095702 (2005-05-01), Alam
patent: 2006/0211109 (2006-09-01), Totey
patent: WO 03/018783 (2003-03-01), None
Oh et al. Derivation and characterization of new human embryonic stem cell lines: SNUhES1, SNUhES2, and SNUhES3. Stem Cells 23:211-219, 2005.
Bongso, A., et al., “Improved quality of human embryos when co-cultured with human ampullary cells,” Human Reproduction, 4(6):706-713 (1989).
Brimble, S., et al., “Karyotypic Stability, Genotyping, Differentiation, Feeder-Free Maintenance, and Gene Expression Sampling in . . . ,” Stem Cells Devel., 13:585-596 (2004).
Carpenter, M.K., “Feeder-free growth of undifferentiated human embryonic stem cells,” Nature Biotechnology, 19(10):971-974 (2001).
Davila, J.C., et al., “Use and Application of Stem Cells in Toxicology,” Toxicological Sciences, 79:214-223 (2004).
Doetschman, T.C., et al., “The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk . . . ,” J. Embryol. exp. Morph., 87:27-45 (1985).
Evans, M.J., et al., “Derivation and Preliminary Characterization of Pluripotent Cell Lines from Porcine and Bovine Blastocysts,” Theriogenology, 33:125-128 (1990).
Evans, M.J., and Kaufman, M.H., “Establishment in culture of pluripotential cells from mouse embryos,” Nature 292:154-156 (1981).
Gardner, D.K., et al., “Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo . . . ,” Fert. Ster., 69(1):84-88 (1998).
Giles, J.R., et al., “Pluripotency of Cultured Rabbit Inner Cell Mass Cells Detected by Isozyme Analysis and Eye Pigmentation . . . ,” Molecular Reprod. Devel., 36:130-138 (1993).
Graves, K. H., and Moreadith, R.W., “Derivation and Characterization of Putative Pluripotential Embryonic Stem Cells from . . . ,” Molecular Reprod. Devel., 36:424-433 (1993).
Hamakazi, T., et al., “Hepatic maturation in differentiating embryonic stem cells in vitro,” FEBS Letters 497:15-19 (2001).
Iannaccone, P.M., et al., “Pluripotent Embryonic Stem Cells from the Rat are Capable of Producing Chimeras,” Developmental Biology, 163:288-292 (1994).
Itskovitz-Eldor, J., et al., “Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers,” Molecular Med. 6(2):88-95 (2000).
Kulkarni, J.S., and Khanna, A., “Functional hepatocyte-like cells derived from mouse embryonic stem cells: A novel in vitro . . . ” Toxicology in Vitro, 20:1014-1022 (2006).
Mandal, A., et al., “Characterization and in vitro differentiation potential of a new human embryonic stem cell line, ReliCell(R)hES1,” Differentiation, 74:81-90 (2006).
Martin, G.R., “Isolation of a Pluripotent Cell Line from Early Mouse Embryos Cultured in Medium Conditioned by . . . ,” Proc. Natl. Acad. Sci. USA 78(12):7634-7638 (1981).
Mehra, N.K., et al., “Molecular diversity of HLA-A*02 in Asian Indians: predominance of A*0211,” Tissue Antigens 57:502-507 (2001).
Meinecke-Tillman S., and Meinecke, B., “Isolation of ES-like cell lines from ovine and caprine preimplantation embryos,” J. Anim. Breed. Genet. 113:413-426 (1996).
Notarianni, E., et al., “Derivation of pluripotent, embryonic cell lines from the pig and sheep,” J. Reprod. Fert., Suppl. 43:255-260 (1991).
Notarianni, E., et al., “Maintenance and differentiation in culture of pluripotential embryonic cell lines from pig blastocysts,” J. Reprod. Fert., Suppl. 41:51-56 (1990).
Reubinoff, B.E., et al., “Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro,” Nature Biotechnology 18:399-404 (2000).
Segev, H., et al., “Differentiation of Human Embryonic Stem Cells into Insulin-Producing Clusters,” Stem Cells, 22:265-274 (2004).
Solter, D., and Knowles, B.B., “Immunosurgery of mouse blastocyst,” Proc. Natl. Acad. Sci., 72(12):5099-5102 (1975).
Sukoyan, M.A., et al., “Isolation and Cultivation of Blastocyst-Derived Stem Cell Lines from American Mink (Mustela vison),” Mol. Reprod. Dev., 33:418-431 (1992).
Thomson, J.A., et al., “Embryonic Stem Cell Lines Derived from Human Blastocysts,” Science, 282:1145-1147 (1998).
Thomson, J.A., and Marshall, V.S., “Primate Embryonic Stem Cells,” Current Topics in Developmental Biology, 38:133-165 (1998).
Thomson, J.A., et al., “Pluripotent Cell Lines from Common Marmoset (Callithrix jacchus) Blastocysts,” Biology of Reproduction 55:254-259 (1996).
Thomson, J.A., et al., “Isolation of a primate embryonic stem cell line,” Proc. Natl. Acad. Sci. USA, 92:7844-7848 (1995).
PCT/IN2006/000169, International Search Report, Jan. 26, 2007.
Bok, H. et al., “Justice, Ethnicity, and Stem-Cell Banks,” The Lancet, 364:118-121, 2004.
Bradley, J.A. et al., “Stem Cell Medicine Encounters the Immune System,” Nature Reviews. Immunology, 2:859-871, 2002.
Josephson, Richard et al., “A Molecular Scheme for Improved Characterization of Human Embryonic Stem Cell Lines,” BMC Biology, 4:28, 2006.
Lee, Jung Bok et al, “Available Human Feeder Cells for the Maintenance of Human Embryonic Stem Cells,” Reproduction, 128:727-735, 2004.
Bose Bipasha
Kahn Alam Firdos
Khanna Aparna
Kulkarni Jayant
Mandal Arundhati
Nguyen Quang
Reliance Life Sciences Pvt. Ltd.
Vinson & Elkins LLP
LandOfFree
Establishment of a human embryonic stem cell line using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Establishment of a human embryonic stem cell line using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Establishment of a human embryonic stem cell line using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4224481